Steven Fischkoff VP, Clinical & Medical Affairs Celgene Steven is currently VP of Clinical and Medical Affairs at Celgene Cellular Therapeutics, focusing on clinical trials of placental derived adherent cells. He has previously held many senior level positions including Global Clinical Leader at Abbott.
Lee Buckler Managing Director, Cell Therapy CTG Consulting Lee is the founder and managing director of Cell Therapy Group, a leading boutique consultancy. He founded Cell Therapy News, created Cell Therapy Blog and serves on the Editorial Board of the journals BioProcess International and Regenerative Medicine.
Rahul Aras President & CEO Juventas Therapeutics Rahul is Juventas’ founding CEO and has transitioned the company from concept to clinical-stage. Rahul was formerly the Director of Life Science Commercialization at Cleveland Clinic Innovations and has extensive experience in negotiating strategic partnerships.
John Sinden CSO ReNeuron John is a scientific co-founder of ReNeuron. He also sits on the Industry Committee of the International Society for Stem Cell Research and the Expert WorkingGroup on Cell and Gene Therapies for the Bioindustry Organization BioSafe Committee.
Adel Nada Senior Medical Director, Cardiovascular Cellular Therapies Baxter Healthcare Adel is a clinical development leader with more than 10 years of clinical research experience. He is currently directing the medical functions of the Cellular Therapies Department, including overall oversight of the Phase 3 Program in Chronic Myocardial Ischemia.
Sicco Popma Scientific Director, Stem Cell Research Janssen Sicco obtained his PH.D in Medical Sciences from the University of Groningen, based on his work performed at the University of Pennsylvania. He is currently Scientific Director at the Cell Therapy group of Janssen R&D.
Gregory Bonfiglio Founder & Managing Partner Proteus Venture Partners Greg is the Founder & Managing Partner of Proteus, LLC, an investment and advisory firm focused solely on regenerative medicine. He has over 25 years experience working with technology companies and has led investments in both biotechnology and IT.
Julie Allickson Director of Translational Research Wake Forest Institute for Regenerative Medicine Julie focuses on the translation of adult and fetal stem cells. Prior to joining the institute, she was an Executive Officer and Vice President of Laboratory Operations at Cryo-Cell International, a Family Cord Blood Bank.
Naomi Aronson Executive Director, Technology Evaluation Center Blue Cross Blue Shield Association Naomi is Executive Director of the Blue Cross and Blue Shield Association Technology Evaluation Center (TEC). She has overseen TEC’s development as a nationally recognized technology assessment program.
Brian Davis Director, Center for Stem Cell & Regenerative Medicine University of Texas Brian has also served as President & CEO of Gene-Cell, Inc., a start-up biotechnology company located in Clear Lake, Texas. His ultimate goal is to develop patient-specific stem cellbased therapeutic approaches.
George Emont Managing Partner Triathlon Medical Ventures George is a Managing Partner with Triathlon Medical Ventures and also a Managing Partner of the Kentucky Seed Capital Fund. His 27 years of health care industry experience include over 16 years in venture capital.
Patrick Ginty Regulatory Affairs Manager Cell Therapy Catapult Limited Patrick collaborates with EU and USbased companies to solve specific regulatory challenges related to the manufacture of regenerative therapies. He has a professional certification in US Regulatory Affairs from the Regulatory Affairs Professional Society.
Gloria Matthews Senior Scientific Director, Orthopaedic Research Genzyme, Sanofi Gloria is currently Senior Scientific Director of Orthopaedic Research at Genzyme, a Sanofi company. She also sits on the board of directors of the Orthopaedic Research Society.
Isabelle Riviere Director, Cell Therapy & Cell Engineering Laboratory Memorial Sloan- Kettering Cancer Center Isabelle serves as a liaison with the FDA for cell and vector manufacturing at MSKCC and develops new INDs and RAC/NIH applications for Phase I/II clinical trials. Additionally, she oversees the manufacture of clinical-grade viral vectors and plasmid DNA at MSKCC.
Warren Sherman Director, Stem Cell Research & Regenerative Medicine Columbia University Medical Center Warren is an Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. He pioneered a technique for injecting stem cells into the heart and performed the first catheter-based injection of adult stem cells into the heart of a patient with congestive heart failure.
Elmar R. Burchardt Vice President Regenerative Medicine, Pfizer Elmar R. Burchardt, M.D., Ph.D., D.Sc. was appointed as Vice President, Regenerative Medicine, at Pfizer Inc. in Cambridge, Massachusetts, in May 2010. Pfizer is currently actively enrolling patients in clinical trials involving cell therapies. Elmar has over 19 years of professional experience in the areas of cell therapy, hematology, cardiovascular diseases and gastroenterology. Read more...
Fabio Triolo Director, Human Cell Processing cGMP Facilities in the Program of Regenerative Medicine University of Texas Fabio is an expert in clinical cell therapy manufacturing, has a broad background in aseptic methods of harvesting, purification, processing, culture, storage and characterization of human cells, and extensive experience in compliance with current Good Manufacturing Practices.
Wouter Van’t Hof Senior Director, Regenerative Medicine Athersys Wouter Van’t Hof, Ph.D. is a Director of Regenerative Medicine at Athersys, Inc., a biotech Company in Cleveland, Ohio. Since 2003, he has focused on preclinical and clinical development of MultiStem®, an adult bone marrow stromal stem cell product.
Patrick Bilbo Vice President, Regulatory Affairs & Government Relations Organogenesis Inc. Patrick Bilbo is responsible for Organogenesis’ Regulatory Affairs, Government Relations and Healthcare Compliance departments. He has over twenty years of experience in industry, with a broad range of expertise in the commercialization of devices, combination products and regenerative medicine therapies. Read more...